Furthermore, previous genome-wide efforts have reported only sub-genome-wide significant results for association with MS severity (6, 29, 30) or for effect size differences in HLA-DRB1*1501 carriers and non-carriers. The gene discussed is HLA-DRB1; the disease is myeloid sarcoma.